E17K substitution in AKT1 in prostate cancer

BACKGROUND: The phosphatidylinositol 3-kinase (PI3K)–AKT pathway is activated in many cancers. Mutational hotspots in AKT1 and in the regulatory and catalytic subunits of PI3K have been detected in multiple tumour types. In AKT1, the E17K substitution leads to a PI3K-independent activation of AKT1....

Full description

Saved in:
Bibliographic Details
Main Authors: Boormans, J L, Korsten, H, Ziel-van der Made, A C J, van Leenders, G J L H, Verhagen, P C M S, Trapman, J
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2010
Subjects:
Short Communication
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2869172/
https://ncbi.nlm.nih.gov/pubmed/20407443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605673
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items